ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea
· Delayed Price · Currency is KRW 7,100.00
-10.00 (-0.14%)
At close: Apr 29, 2026
ImmuneOncia Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 8,238 | 8,226 | 20,957 | 26,730 | 36,320 | Upgrade
|
| Short-Term Investments | 15,200 | 3,100 | 5,000 | - | 6,000 | Upgrade
|
| Cash & Short-Term Investments | 23,438 | 11,326 | 25,957 | 26,730 | 42,320 | Upgrade
|
| Cash Growth | 106.93% | -56.36% | -2.89% | -36.84% | 104.10% | Upgrade
|
| Accounts Receivable | - | 421.83 | 11 | 633.65 | - | Upgrade
|
| Other Receivables | 128.37 | 7,709 | 172.13 | 202.16 | 41.53 | Upgrade
|
| Receivables | 128.37 | 8,131 | 183.13 | 835.81 | 41.53 | Upgrade
|
| Prepaid Expenses | 2,475 | 297.34 | 376.95 | 520.18 | 232.62 | Upgrade
|
| Other Current Assets | 465.54 | 107.93 | 118.97 | 884.02 | 72.89 | Upgrade
|
| Total Current Assets | 26,506 | 19,863 | 26,636 | 28,970 | 42,667 | Upgrade
|
| Property, Plant & Equipment | 649 | 494.54 | 892.1 | 547.33 | 997.96 | Upgrade
|
| Other Intangible Assets | 4,503 | 4,908 | 5,429 | 5,987 | 6,503 | Upgrade
|
| Other Long-Term Assets | 1,487 | 930.02 | 838.32 | 188.36 | 932.89 | Upgrade
|
| Total Assets | 33,146 | 26,195 | 33,795 | 35,693 | 51,101 | Upgrade
|
| Accrued Expenses | 138.88 | 137.63 | 103.34 | 154.4 | 128.24 | Upgrade
|
| Current Portion of Leases | 54.98 | 51.05 | 50.11 | 98.69 | 216.39 | Upgrade
|
| Current Unearned Revenue | 1,950 | 1,950 | 1,950 | 1,950 | 6,902 | Upgrade
|
| Other Current Liabilities | 2,115 | 4,354 | 1,268 | 1,646 | 1,578 | Upgrade
|
| Total Current Liabilities | 4,259 | 6,493 | 3,372 | 3,850 | 8,824 | Upgrade
|
| Long-Term Leases | 14.55 | 44.01 | 86.83 | 24.27 | 98.24 | Upgrade
|
| Pension & Post-Retirement Benefits | 139.2 | 15.06 | 14.27 | - | 184.09 | Upgrade
|
| Other Long-Term Liabilities | 317.13 | 219.18 | 236.63 | 84,226 | 101,526 | Upgrade
|
| Total Liabilities | 4,730 | 6,771 | 3,710 | 88,100 | 110,633 | Upgrade
|
| Common Stock | 37,083 | 36,365 | 26,896 | 26,141 | 25,503 | Upgrade
|
| Additional Paid-In Capital | 115,752 | 79,021 | 35,292 | 28,046 | 22,148 | Upgrade
|
| Retained Earnings | -138,091 | -110,721 | -105,016 | -113,921 | -110,518 | Upgrade
|
| Comprehensive Income & Other | 13,672 | 14,759 | 8,637 | 7,326 | 3,336 | Upgrade
|
| Total Common Equity | 28,415 | 19,424 | -34,192 | -52,407 | -59,532 | Upgrade
|
| Shareholders' Equity | 28,415 | 19,424 | 30,086 | -52,407 | -59,532 | Upgrade
|
| Total Liabilities & Equity | 33,146 | 26,195 | 33,795 | 35,693 | 51,101 | Upgrade
|
| Total Debt | 69.53 | 95.06 | 136.94 | 122.97 | 314.63 | Upgrade
|
| Net Cash (Debt) | 23,368 | 11,231 | 25,820 | 26,607 | 42,005 | Upgrade
|
| Net Cash Growth | 108.06% | -56.50% | -2.96% | -36.66% | 103.58% | Upgrade
|
| Net Cash Per Share | 333.06 | 199.46 | 492.28 | 510.53 | 904.13 | Upgrade
|
| Filing Date Shares Outstanding | 73.96 | 56.31 | 52.45 | 52.12 | 46.46 | Upgrade
|
| Total Common Shares Outstanding | 73.96 | 56.31 | 52.45 | 52.12 | 46.46 | Upgrade
|
| Working Capital | 22,247 | 13,370 | 23,264 | 25,120 | 33,842 | Upgrade
|
| Book Value Per Share | 384.21 | 344.97 | -651.90 | -1005.59 | -1281.39 | Upgrade
|
| Tangible Book Value | 23,913 | 14,516 | -39,621 | -58,394 | -66,035 | Upgrade
|
| Tangible Book Value Per Share | 323.33 | 257.81 | -755.41 | -1120.48 | -1421.36 | Upgrade
|
| Machinery | 1,797 | 1,514 | 1,443 | 1,173 | 1,148 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.